Tenet Healthcare Corporation (NYSE:THC) Receives $244.16 Average Price Target from Brokerages

Shares of Tenet Healthcare Corporation (NYSE:THC) have received an average rating of “Moderate Buy” from the twenty-two ratings firms that are presently covering the firm, MarketBeat.com reports. Four analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $244.1579.

A number of research analysts have commented on THC shares. TD Cowen reiterated a “buy” rating on shares of Tenet Healthcare in a research note on Thursday, February 12th. Guggenheim decreased their price target on Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating for the company in a research note on Friday, May 1st. Wall Street Zen cut Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, May 11th. Barclays decreased their target price on Tenet Healthcare from $257.00 to $238.00 and set an “overweight” rating for the company in a research report on Tuesday, May 5th. Finally, Truist Financial upped their price target on Tenet Healthcare from $240.00 to $270.00 and gave the company a “buy” rating in a research report on Tuesday, February 17th.

Tenet Healthcare Stock Down 1.5%

Shares of Tenet Healthcare stock opened at $163.90 on Wednesday. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30. Tenet Healthcare has a 1-year low of $146.60 and a 1-year high of $247.21. The business has a 50-day moving average of $185.02 and a 200-day moving average of $200.40. The company has a market capitalization of $14.12 billion, a PE ratio of 8.50, a P/E/G ratio of 1.34 and a beta of 1.28.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, beating analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The firm had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.39 billion. During the same quarter last year, the firm earned $4.36 EPS. Tenet Healthcare’s quarterly revenue was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, equities analysts forecast that Tenet Healthcare will post 17.61 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director J Robert Kerrey sold 5,638 shares of the company’s stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total value of $983,943.76. Following the completion of the sale, the director owned 16,804 shares in the company, valued at $2,932,634.08. This represents a 25.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Nadja West sold 3,000 shares of the company’s stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total transaction of $532,050.00. Following the sale, the director directly owned 24,805 shares of the company’s stock, valued at $4,399,166.75. This represents a 10.79% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.97% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Tenet Healthcare

Several large investors have recently made changes to their positions in THC. NewEdge Advisors LLC lifted its position in shares of Tenet Healthcare by 6.1% in the first quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock worth $389,000 after buying an additional 166 shares during the last quarter. Jones Financial Companies Lllp raised its position in shares of Tenet Healthcare by 299.1% in the first quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock valued at $229,000 after purchasing an additional 1,274 shares during the period. Sivia Capital Partners LLC bought a new stake in shares of Tenet Healthcare during the 2nd quarter worth $290,000. Quantbot Technologies LP acquired a new position in Tenet Healthcare in the 2nd quarter valued at $65,000. Finally, Amundi lifted its position in Tenet Healthcare by 4,207.8% during the 2nd quarter. Amundi now owns 27,010 shares of the company’s stock worth $4,652,000 after acquiring an additional 26,383 shares during the last quarter. Institutional investors own 95.44% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.